These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38675980)

  • 1. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
    Freidel MR; Vakhariya PA; Sardarni SK; Armen RS
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
    Freidel MR; Armen RS
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein.
    Freidel MR; Armen RS
    J Chem Inf Model; 2021 Dec; 61(12):5906-5922. PubMed ID: 34898207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights.
    Borisevich SS; Khamitov EM; Gureev MA; Yarovaya OI; Rudometova NB; Zybkina AV; Mordvinova ED; Shcherbakov DN; Maksyutov RA; Salakhutdinov NF
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein.
    Sun C; Zhang J; Wei J; Zheng X; Zhao X; Fang Z; Xu D; Yuan H; Liu Y
    PLoS One; 2021; 16(1):e0245975. PubMed ID: 33493227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia.
    Singh SK; Singh S; Singh R
    J Ovarian Res; 2021 Sep; 14(1):126. PubMed ID: 34579761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
    Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
    J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
    Yuan S; Yin X; Meng X; Chan JF; Ye ZW; Riva L; Pache L; Chan CC; Lai PM; Chan CC; Poon VK; Lee AC; Matsunaga N; Pu Y; Yuen CK; Cao J; Liang R; Tang K; Sheng L; Du Y; Xu W; Lau CY; Sit KY; Au WK; Wang R; Zhang YY; Tang YD; Clausen TM; Pihl J; Oh J; Sze KH; Zhang AJ; Chu H; Kok KH; Wang D; Cai XH; Esko JD; Hung IF; Li RA; Chen H; Sun H; Jin DY; Sun R; Chanda SK; Yuen KY
    Nature; 2021 May; 593(7859):418-423. PubMed ID: 33727703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Antiviral Drug Arbidol Inhibits Infection by SARS-CoV-2 and Variants through Direct Binding to the Spike Protein.
    Shuster A; Pechalrieu D; Jackson CB; Abegg D; Choe H; Adibekian A
    ACS Chem Biol; 2021 Dec; 16(12):2845-2851. PubMed ID: 34792325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Mondal S; Karmakar A; Mallick T; Begum NA
    Virology; 2021 Apr; 556():133-139. PubMed ID: 33571798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.
    Xia S; Yan L; Xu W; Agrawal AS; Algaissi A; Tseng CK; Wang Q; Du L; Tan W; Wilson IA; Jiang S; Yang B; Lu L
    Sci Adv; 2019 Apr; 5(4):eaav4580. PubMed ID: 30989115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Binding Pockets in the Conformational States of the SARS-CoV-2 Spike Trimers for the Screening of Allosteric Inhibitors Using Molecular Simulations and Ensemble-Based Ligand Docking.
    Gupta G; Verkhivker G
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoprotein.
    Shi Y; Zeida A; Edwards CE; Mallory ML; Sastre S; Machado MR; Pickles RJ; Fu L; Liu K; Yang J; Baric RS; Boucher RC; Radi R; Carroll KS
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35074895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
    Zeng MS; Yu WD; Wang HX; Liu JY; Xu PP
    Int J Biol Macromol; 2021 Jul; 183():2248-2261. PubMed ID: 34111482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Modified Fibronectin Type III Domain-Conjugated, Long-Acting Pan-Coronavirus Fusion Inhibitor with Extended Half-Life.
    Duan Q; Xia S; Jiao F; Wang Q; Wang R; Lu L; Jiang S; Xu W
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.
    Kim SY; Jin W; Sood A; Montgomery DW; Grant OC; Fuster MM; Fu L; Dordick JS; Woods RJ; Zhang F; Linhardt RJ
    Antiviral Res; 2020 Sep; 181():104873. PubMed ID: 32653452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaffold morphing of arbidol (umifenovir) in search of multi-targeting therapy halting the interaction of SARS-CoV-2 with ACE2 and other proteases involved in COVID-19.
    Choudhary S; Silakari O
    Virus Res; 2020 Nov; 289():198146. PubMed ID: 32866534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.